Stock IMNN IMUNON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Imunon, Inc.

Equities

IMNN

US15117N6022

Real-time Estimate Cboe BZX
Other stock markets
 03:49:03 2024-05-03 pm EDT 		5-day change 1st Jan Change
1.355 USD +3.44% Intraday chart for Imunon, Inc. -6.94% +97.06%
Apr. 18 Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine MT
Apr. 18 Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine DJ

Evolution of the average Target Price on Imunon, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2833c693ef.SRopUcSrUJ2EtoTRoDY5zFvEuYoP_c82NZ97mJxDdII.JDdBBfXNI8Lx__Gz0l0B_SGs9uZiu6YOYfIKtdArAft_Wxk1vvti0sXl5w~e5097ae04bf086c78e492e63d7274001

Analyst Recommendations on Imunon, Inc.

HC Wainwright Adjust Price Target on Imunon to $13 From $12, Keeps Buy Rating MT
Alliance Global Starts Imunon at Buy with $15 Price Target MT
HC Wainwright Starts Celsion at Buy With $16 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.31 USD
Average target price
12 USD
Spread / Average Target
+816.03%
High Price Target
15 USD
Spread / Highest target
+1,045.04%
Low Price Target
8 USD
Spread / Lowest Target
+510.69%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Imunon, Inc.

HC Wainwright
Alliance Global Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. IMNN Stock
  4. Consensus Imunon, Inc.